Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_assertion description "[Expression levels of the cell surface glycoprotein, CD7, and the serine protease, elastase 2 (ELA2), in the leukemic cells of patients with chronic myeloid leukemia (CML) have been associated with clinical outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_assertion evidence source_evidence_literature NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_assertion SIO_000772 20175919 NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_assertion wasDerivedFrom befree-20150227 NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_assertion wasGeneratedBy ECO_0000203 NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.
- befree-20150227 importedOn "2015-02-27" NP425914.RACFziT4pgAeWgyX6shhy5-z0Jy6YDJQTfkuTmSDNLCDw130_provenance.